Adial Appoints Renowned Pharmaceutical Executive Cary J. Claiborne to Board of Directors

NEXT STORY
Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group
PREV STORY
European Medicines Agency Grants Orphan Drug Designation to Rafael Pharmaceuticals’ CPI-613® (Devimistat) for Treatment of Patients with Relapsed or Refractory Burkitt’s Lymphoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Quipt Enters Four New States With Closings of Strategic Acquisitions

author_avatar
NASDAQ Market News

Talaris Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

author_avatar
NASDAQ Market News